Moreover, there was a significant increase in tumour-free survival in DMBA-treated Cfms-TbrII mice compared to Cfms-rtTA (p = 0.02) and TetO-TbrII (p = 0.004) mice (log rank analysis; Fig. 7a). The gene discussed is TGFBR2; the disease is neoplasm.